Work

Subgroup analyses by disease volume and de novo /recurrent mHSPC in the PSMAddition study of [ 177 Lu]Lu-PSMA-617.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5020

Authors: Fred Saad, Scott T. Tagawa, Alton Oliver Sartor, Karim Olivier Fizazi, Alison Helen Reid, Himisha Beltran, Josep M. Piulats, Gero Kramer, Hakim Mahammedi, Matthias Eiber, Shilpa Gupta, Olga V. Sakharova, Emmanuel Bouillaud, Michael J. Morris

Institutions: Centre Hospitalier de l’Université de Montréal, Université de Montréal, Weill Cornell Medicine, Université Paris-Saclay, Centre Oscar Lambret, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Dana-Farber Cancer Institute, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Medical University of Vienna, Centre Jean Perrin, Technical University of Munich, Cleveland Clinic, Novartis (Switzerland), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162536268

Cites:

Cited by: 2

Related to: